HNF4A and type 2 diabetes mellitus: Consistently, reduced Lp(a), apolipoprotein (AII), and apolipoprotein (CIII) levels have been observed in patients with maturity-onset diabetes of the young (MODY) carrying the HNF4A (Q268X) mutation (23).